| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure
|
Langenickel, Thomas H.
|
|
2012
|
9 |
4 |
p. e131-e139
nvt p.
|
artikel
|
| 2 |
Beta-arrestin-biased ligands at the AT1R: a novel approach to the treatment of acute heart failure
|
Violin, Jonathan D.
|
|
2012
|
9 |
4 |
p. e149-e154
nvt p.
|
artikel
|
| 3 |
Contents
|
|
|
2012
|
9 |
4 |
p. i-
1 p.
|
artikel
|
| 4 |
G protein-coupled receptor kinase 2 as a therapeutic target for heart failure
|
Schumacher-Bass, Sarah M.
|
|
2012
|
9 |
4 |
p. e155-e162
nvt p.
|
artikel
|
| 5 |
Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
|
Patel, Vaibhav B.
|
|
2012
|
9 |
4 |
p. e141-e148
nvt p.
|
artikel
|
| 6 |
Old and new biomarkers of oxidative stress in heart failure
|
Menazza, Sara
|
|
2012
|
9 |
4 |
p. e189-e198
nvt p.
|
artikel
|
| 7 |
p38 mitogen activated protein kinase. Do we need a new therapeutic strategy?
|
Martin, Eva Denise
|
|
2012
|
9 |
4 |
p. e183-e188
nvt p.
|
artikel
|
| 8 |
Protein kinase signaling at the crossroads of myocyte life and death in ischemic heart disease
|
Vagnozzi, Ronald J.
|
|
2012
|
9 |
4 |
p. e173-e182
nvt p.
|
artikel
|
| 9 |
Reconsidering phenotypic heart failure drug discovery
|
Toomey, John R.
|
|
2012
|
9 |
4 |
p. e199-e203
nvt p.
|
artikel
|
| 10 |
The challenge of heart failure drug discovery
|
Willette, Robert N.
|
|
2012
|
9 |
4 |
p. e129-e130
nvt p.
|
artikel
|
| 11 |
The yin and yang of adaptive and maladaptive processes in heart failure
|
Bernardo, Bianca C.
|
|
2012
|
9 |
4 |
p. e163-e172
nvt p.
|
artikel
|
Tijdschrift beschrijving